Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit
Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit have?
Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit has 68 citations in the OpenAlex counts ScholarIQ stores.
When was Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit published?
Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit has 2013 year in the ScholarIQ index.
What is the open-access status of Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit?
Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit has bronze oa status in the ScholarIQ index.
What is the DOI of Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit?
The DOI for Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit is on the source record.
What is the PMID of Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit?
The PMID for Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit is on the source record.
What is the OpenAlex record for Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit?
The OpenAlex for Rotigotine polyoxazoline conjugate SER‐214 provides robust and sustained antiparkinsonian benefit is on the source record.